Travere Therapeutics is Friday's IBD Stock Of The Day. The biotech stock is eyeing two potential entries and a second approval for Filspari.
IBD Stock Of The Day Travere Therapeutics: A Breakout And $1 Billion Opportunity Loom Investor's Business Daily.
Read More Details
Finally We wish PressBee provided you with enough information of ( IBD Stock Of The Day Travere Therapeutics: A Breakout And $1 Billion Opportunity Loom )
Also on site :